Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $5.5 million.

  • Surgery Partners' Tax Provisions rose 2222.22% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.2 million, marking a year-over-year increase of 53232.32%. This contributed to the annual value of $134.6 million for FY2024, which is 4496666.67% up from last year.
  • Latest data reveals that Surgery Partners reported Tax Provisions of $5.5 million as of Q3 2025, which was up 2222.22% from -$1.1 million recorded in Q2 2025.
  • Surgery Partners' 5-year Tax Provisions high stood at $120.8 million for Q4 2024, and its period low was -$7.8 million during Q2 2023.
  • Over the past 5 years, Surgery Partners' median Tax Provisions value was $4.4 million (recorded in 2022), while the average stood at $9.6 million.
  • In the last 5 years, Surgery Partners' Tax Provisions crashed by 35000.0% in 2021 and then skyrocketed by 191333.33% in 2024.
  • Over the past 5 years, Surgery Partners' Tax Provisions (Quarter) stood at $11.8 million in 2021, then decreased by 16.1% to $9.9 million in 2022, then plummeted by 39.39% to $6.0 million in 2023, then soared by 1913.33% to $120.8 million in 2024, then tumbled by 95.45% to $5.5 million in 2025.
  • Its Tax Provisions was $5.5 million in Q3 2025, compared to -$1.1 million in Q2 2025 and $120.8 million in Q4 2024.